These results suggest that the downregulation of ARHGAP44 expression may inhibit the proliferation, invasion, and migration of osteosarcoma tumor cells through the p53/C-myc/Cyclin D1 pathway (Fig. 5). This evidence concerns the gene MYC and osteosarcoma.